Newsletter
FDA Calendar
Market Data
Heat Map
Screener
Insider Trades
LOGIN
|
REGISTER
Index
Newsroom
Featured Stocks
Free Daily Newsletter
Stock Lists
See All Health Stock Lists
Biotechnology Stocks
Pharmaceutical Stocks
Big Pharma Stocks
Healthcare Stocks
Medical Stocks
Diagnostics & Research Stocks
Medical Device Stocks
Biotechnology News
Pharmaceutical News
Medical News
Healthcare News
Register
FDA Calendar
Market Data
Stock Screener
Insider Trades
Search
Logout
Newsroom
Featured Stocks
Stock Lists
Biotech
Pharma
Medical
Healthcare
Watch List
Recent Insider Transactions - Jupiter Neurosciences (NASDAQ: JUNS)
Follow
NASDAQ:JUNS
Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
07/01/2025
Buy
$1.03
250
$259
112,777
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
07/01/2025
Buy
$1.03
250
$257
112,527
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
07/01/2025
Buy
$1.03
250
$257
112,277
NASDAQ
JUNS
Jupiter Neurosciences
ROSEN CHRISTER
/
director, 10 percent owner, officer: CEO and Chairman
07/01/2025
Buy
$1.02
3,100
$3K
11.08M
NASDAQ
JUNS
Jupiter Neurosciences
ROSEN CHRISTER
/
director, 10 percent owner, officer: CEO and Chairman
07/01/2025
Buy
$1.01
500
$505
11.08M
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
06/30/2025
Buy
$1.05
100
$105
112,027
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
06/30/2025
Buy
$1.04
250
$259
111,927
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
06/30/2025
Buy
$1.03
250
$258
111,677
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
06/30/2025
Buy
$1.02
100
$102
111,177
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
06/27/2025
Buy
$1.05
250
$263
111,077
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
06/27/2025
Buy
$1.04
250
$261
110,827
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
06/27/2025
Buy
$1.04
100
$104
110,577
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
06/27/2025
Buy
$1.00
250
$250
110,477
NASDAQ
JUNS
Jupiter Neurosciences
Silva Alison D.
/
director, officer: Pres + Chief Business Officer
06/30/2025
Buy
$1.02
250
$255
111
NASDAQ
JUNS
Jupiter Neurosciences
ROSEN CHRISTER
/
director, 10 percent owner, officer: CEO and Chairman
06/30/2025
Buy
$1.05
1,000
$1K
11.08M
NASDAQ
JUNS
Jupiter Neurosciences
ROSEN CHRISTER
/
director, 10 percent owner, officer: CEO and Chairman
06/30/2025
Buy
$1.04
1,500
$2K
11.07M
NASDAQ
JUNS
Jupiter Neurosciences
ROSEN CHRISTER
/
director, 10 percent owner, officer: CEO and Chairman
06/30/2025
Buy
$1.03
700
$721
11.07M
NASDAQ
JUNS
Jupiter Neurosciences
ROSEN CHRISTER
/
director, 10 percent owner, officer: CEO and Chairman
06/30/2025
Buy
$1.02
1,450
$1K
11.07M
NASDAQ
JUNS
Jupiter Neurosciences
ROSEN CHRISTER
/
director, 10 percent owner, officer: CEO and Chairman
06/30/2025
Buy
$1.01
2,000
$2K
11.07M
NASDAQ
JUNS
Jupiter Neurosciences
ROSEN CHRISTER
/
director, 10 percent owner, officer: CEO and Chairman
06/30/2025
Buy
$0.98
1,000
$980
11.07M
NASDAQ
JUNS
Jupiter Neurosciences
ROSEN CHRISTER
/
director, 10 percent owner, officer: CEO and Chairman
06/27/2025
Buy
$1.06
166
$176
11.07M
Research Tools
Stock Screener
FDA Catalyst Calendar
Insider Transactions
Life Science Stock Lists
All Life Science Stocks
News & Announcements
All Life Science News
Clinical Trial News
Company FDA Updates
Mergers & Acquisitions
Search News & Events
Popular Topics
Top Stocks in 2025
Big Pharma Stocks
Artificial Intelligence
Obesity Drugs
Psychedelic Stocks
Miscellaneous
Free Daily Newsletter
Follow Us On X
Advertise
Privacy Policy
Disclaimer
Tweet
Share
Share
Share
Share
Sign Up To Get Daily
Life Science News
Register
or
Login
to Access Entire Platform.